Oncology & Cancer

Genetic study of liver cancer reveals new drug target

Drugs targeting the gene MAGEA3 may help block the growth of hepatocellular carcinoma (HCC), the most common type of primary liver cancer and one of the leading causes of cancer deaths in the country. That's one conclusion ...

Medical research

Identification of all types of germ cells tumors

Germ cell tumors constitute a diverse group of rare tumors, which occur in the testes, ovaries and also in other places. Some germ cell tumors exist prenatally, while others present during or after puberty. The majority are ...

Oncology & Cancer

Researchers map the genome of testicular cancer

Testicular germ cell cancer, a disease that is rare but growing in incidence in men in the United States, is considered to be among the most curable of solid tumors. Now researchers from the University of North Carolina Lineberger ...

Oncology & Cancer

Study sheds new light on inherited testicular cancer risk

An analysis of data from five major studies of testicular cancer has identified new genetic locations that could be susceptible to inherited testicular germ cell tumors. The findings, which researchers call a success story ...

Oncology & Cancer

Scientists identify unique genomic features in testicular cancer

Researchers led by scientists at Dana-Farber Cancer Institute say they have identified unique genomic changes that may be integral to testicular cancer development and explain why the great majority are highly curable with ...

Oncology & Cancer

TP53, MDM2 alterations linked to cisplatin resistance in GCT

(HealthDay)—In germ cell tumors (GCTs), TP53 and MDM2 alterations correlate with cisplatin resistance and are associated with inferior outcome, according to a study published online Sept. 19 in the Journal of Clinical Oncology.

page 1 from 2